Plasmid-free AAV production technology enhances yield, purity, and scalability, enabling reduced variability, and consistent high-quality vectors for gene therapy.
Integrated antibody discovery services accelerate lead generation and optimization with advanced platforms, bioassays, and pharmacology for diverse biologics modalities.
Gain insight into a CDMO with global, end-to-end mammalian manufacturing solutions, proven expertise, flexible capacity, and a strong track record in regulatory compliance.
USP <382> testing assesses packaging integrity, safety, and performance using deterministic CCIT and functional evaluations to support validation and regulatory submissions.
Scale your viral vector program with confidence: 20+ years CGMP experience, 1,200+ GMP lots, and 3 approved products. Access full-service manufacturing from IND to commercial.
Explore a custom lentiviral vector design and manufacturing offering for programs where complex biology is driving development and early decisions have long-term consequences.
Engineered circular DNA formats enable efficient, low‑toxicity gene editing with high stability, customizable architectures, reduced immune activation, and broad applicability.
Optimize AAV gene therapy development with construct and process enhancements, boosting titers, potency, and scalability for cost-efficient manufacturing and accelerated timelines.
